Treatments

Lung Cancer Treatment Decisions: What If Genetic Tests Don’t Reveal a Driver Mutation?

How do genetic test results influence lung cancer treatment decisions? Listen as Dr.Lecia Sequist andJanet Freeman-Daily discuss driver mutations and targeted therapies.

Lecia Sequist, MD, MPH - DF/HCC, Janet Freeman-Daily, Andrew Schorr

Early Palliative Care Eases Symptoms of Lung Cancer

Although stage IV lung cancer is not curable, there are ways to prolong the patient's life and provide better quality of life. Read to learn about the impact of early palliative care on symptoms.

Lauren Evoy Davis

Latest News

FDA Approves Second RET Inhibitor for NSCLC

What KRAS Clinical Trials Are Available?

Jyoti D. Patel, MD, Jessica Lin, MD, Terri Conneran

The Latest in KRAS Lung Cancer Treatment

Clinical Trials For EGFR Lung Cancer

Alex Spira, MD, PhD, FACP, Bruce E. Johnson, MD, Mike Smith, Jill Feldman, Andrea Hutton

FDA Approved Oncology Drugs for 2020

What is the First Line Treatment for EGFR-Mutant NSCLC?

Bruce E. Johnson, MD, Alex Spira, MD, PhD, FACP

EGFR Lung Cancer Treatment News

Bruce E. Johnson, MD, Alex Spira, MD, PhD, FACP, Andrea Hutton

Small Cell and Non-Small Cell Lung Cancer Updates

Andrew Schorr, Heather Wakelee, MD

An Expert’s Insight to Lung Cancer Treatment Developments

D. Ross Camidge, MD, PhD, Laura Levaas

Why Should Lung Cancer Patients Consider a Clinical Trial?

Jessica Wittebort, Lecia Sequist, MD, MPH - DF/HCC, Janet Freeman-Daily, Andrew Schorr

Will CAR T-Cell Therapy Benefit Lung Cancer Patients?

Jhanelle Gray, MD, Andrew Schorr

What Role Does Radiation Play in Lung Cancer Care?

Stephen A. Rosenberg, MD, MS, Jhanelle Gray, MD, Andrew Schorr